CV Sciences, Inc.
CVSI
$0.02
$0.008.33%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -14.90% | -12.61% | -12.20% | -8.04% | -5.50% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -14.90% | -12.61% | -12.20% | -8.04% | -5.50% |
| Cost of Revenue | -19.17% | -19.36% | -17.57% | -9.31% | -6.20% |
| Gross Profit | -9.99% | -4.55% | -5.80% | -6.57% | -4.67% |
| SG&A Expenses | -14.12% | -12.09% | -11.91% | -11.07% | -7.13% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 100.00% | 100.00% | -- | -- | -- |
| Total Operating Expenses | -14.08% | -12.92% | -17.62% | -13.15% | -9.63% |
| Operating Income | 1.52% | 17.80% | 70.68% | 56.58% | 45.76% |
| Income Before Tax | -28.22% | 20.83% | 60.49% | 41.54% | 38.40% |
| Income Tax Expenses | 200.00% | 128.57% | 212.50% | -133.33% | -133.33% |
| Earnings from Continuing Operations | -29.25% | 20.43% | 59.98% | 41.74% | 38.61% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -29.25% | 20.43% | 59.98% | 41.74% | 38.61% |
| EBIT | 1.52% | 17.80% | 70.68% | 56.58% | 45.76% |
| EBITDA | -34.36% | -7.59% | 78.09% | 67.09% | 58.34% |
| EPS Basic | -23.81% | 23.08% | 62.04% | 48.05% | 46.84% |
| Normalized Basic EPS | 15.69% | 6.52% | 47.69% | 39.73% | 28.17% |
| EPS Diluted | -94.05% | -33.65% | 18.98% | 48.39% | 47.17% |
| Normalized Diluted EPS | 15.69% | 6.52% | 47.69% | 39.73% | 28.17% |
| Average Basic Shares Outstanding | 3.46% | 2.27% | 4.98% | 9.33% | 13.69% |
| Average Diluted Shares Outstanding | 3.46% | 2.27% | 4.98% | 9.33% | 13.69% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |